Transport
Sheridan Memorial Hospital Association
Sheridan Memorial Hospital Association was paid $48K by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99285, emergency room visit (most serious) — 15% of everything it billed.
33Billing provider infoSHERIDAN MEMORIAL HOSPITAL ASSOCIATION
PLENTYWOOD, MT 59254
PLENTYWOOD, MT 59254
33aNPI1467452102assigned 07/22/2005
33bProvider typeAmbulance
28Total paid$48K
24GClaims9,634
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulance providers in Montana
Rank by total paid#13 of 16
Median peer was paid$93K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,249 | $7K | |
| 2019 | 1,002 | $5K | |
| 2020 | 886 | $2K | |
| 2021 | 1,243 | $5K | |
| 2022 | 1,405 | $7K | |
| 2023 | 2,007 | $14K | |
| 2024incomplete | 1,842 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 94 | 80 | $7K |
| 80053 | Comprehensive metabolic panel | 12% | 1,865 | 1,495 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 9.5% | 277 | 221 | $5K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.1% | 159 | 126 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.5% | 1,728 | 1,377 | $3K |
| A0425 | Ground mileage, per statute mile | 6.3% | 19 | 12 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.3% | 242 | 220 | $3K |
| 36415 | Collection of venous blood by venipuncture | 6.2% | 3,501 | 2,658 | $3K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.2% | 58 | 41 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.9% | 171 | 63 | $2K |
| 86140 | 3.6% | 310 | 255 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 70 | 30 | $1K |
19 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 161 | $1K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 90 | $938.24 |
| 83735 | 1.8% | 291 | $885.55 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.8% | 30 | $878.85 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 31 | $770.62 |
| 81000 | 1.2% | 169 | $561.57 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 21 | $270.02 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 21 | $235.34 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 30 | $195.62 |
| 87634 | <1% | 21 | $185.40 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 25 | $60.97 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 70 | $37.79 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 13 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 16 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 32 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 25 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 56 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 26 | $0.00 |
| 83605 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNELSON, KODAY (CEO)